$VRTX, Long, TP>25% NASDAQ:VRTX , Long, TP>25%
Fundamentally the stock is good.
Choose an entry point and do not forget about a protective order if you are trading with leverage.
Don't risk it if you're not sure.
Good luck to everyone.
−0.00 BRL
18.08 B BRL
49.14 B BRL
About Vertex Pharmaceuticals Incorporated
Sector
CEO
Reshma Kewalramani
Headquarters
Boston
Website
Founded
1989
ISIN
BRVRTXBDR001
FIGI
BBG00P14KF71
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
VRTX"A quick trade for traders based on a classic, well-known pattern: Symmetrical Triangle. Entry at $500, stop loss at $460. First target between $527.5 _ $535. Second target between $544 _ $549."
VRTXThe VRTX stock has broken the ascending channel and successfully retested it. It is now ready to be sold with a first target between $404.60 and $403, and a second target of $375.50. The stop loss is at $500.
VRTX Vertex Pharmaceuticals Options Ahead of EarningsAnalyzing the options chain and the chart patterns of VRTX Vertex Pharmaceuticals prior to the earnings report this week,
I would consider purchasing the 472.5usd strike price Puts with
an expiration date of 2024-11-8,
for a premium of approximately $14.00.
If these options prove to be profitable pr
Vertex Pharmaceuticals (VRTX) | Chart & Forecast SummaryRight Here You Can See Vertex Pharmaceuticals Incorporated (VRTX) Registered As (VRTX) On The New York Stock Exchange, Vertex Pharmaceuticals Incorporated Is An American Biopharmaceutical Company Based In Boston, Massachusetts.
The Following Chart & Forecast Summary On Vertex Pharmaceuticals Incorp
VRTX Bull FlagVRTX is approaching the top end of bull flag on the 4hr. A break could lead to a move back up to ATH and beyond. The flag pole on this one is pretty big so if going on that projection it could see $600 if it does get continuation above.
A bearish scenario would be a rejection here at the top end or
Buy Vertex PharmaceuticalsShort Term Trading Advice by Naranj Capital
Buy Vertex Pharmaceuticals
● Buy Range- 475 - 480
● Target- 500 - 505
● StopLoss- 460
● Potential Return- 5-6%
● Duration- 12-14 Trading Days
VRTX upside?Beautiful bullflag breaking on the hourly and higher time frames, Targeting previous highs
Eyes on VRTXVRTX bouncing nicely off recent lows and has broken downtrend. Final confirmation would be a daily close over 421.50. Looking to enter a starter position and will add on a retest of the daily 48.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where VRTX34 is featured.
